Skip to main navigation Skip to search Skip to main content

Novel antiglaucoma prodrugs and codrugs of ethacrynic acid

  • New England Eye Center
  • University of Kentucky

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

The purpose of this study was to synthesize a novel prodrug of ethacrynic acid (ECA) with short chain polyethylene glycols (PEGs) and codrugs of ECA with the β-adrenergic blocking agent atenolol (ATL) or timolol (TML) to overcome the adverse effects of ECA and to enhance its physicochemical properties.

Original languageEnglish
Pages (from-to)3524-3527
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume15
Issue number15
DOIs
StatePublished - 1 Aug 2005
Externally publishedYes

Keywords

  • Atenolol
  • Codrug
  • Ethacrynic acid
  • Glaucoma
  • Prodrug
  • Timolol

Fingerprint

Dive into the research topics of 'Novel antiglaucoma prodrugs and codrugs of ethacrynic acid'. Together they form a unique fingerprint.

Cite this